Rivernorth Capital Management’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Rivernorth Capital Management’s Portfolio BIOSU Stock Details BIOSU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-99,359	Closed	-$1.04M	–	658
2023 Q1	$1.04M	Hold	99,359	–	–	0.05%	266
2022 Q4	$1.07M	Hold	99,359	–	–	0.05%	306
2022 Q3	$1M	Hold	99,359	–	–	0.04%	376
2022 Q2	$1M	Hold	99,359	–	–	0.04%	355
2022 Q1	$993K	Sell	99,359 -641	-0.6%	-$6.4K	0.04%	374
2021 Q4	$1M	Buy	+100,000	New	+$1M	0.04%	315

Other funds holding BIOSU

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Rivernorth Capital Management's BIOSU Position: Q2 2023 in Review

Rivernorth Capital Management sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q2 2023, closing a stake of 99,359 shares — an estimated $1.04M sold.

Rivernorth Capital Management first reported a position in BIOSU in Q4 2021 and held it in 6 quarters. The position peaked at $1.07M in Q4 2022. 2 funds tracked by Wall St. Rank hold BIOSU as of Q2 2023.

Rivernorth Capital Management reported no remaining BioPlus Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
Rivernorth Capital Management sold 99,359 BioPlus Acquisition Corp. Unit shares in Q2 2023, an estimated $1.04M.
Rivernorth Capital Management first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 6 quarters.
Rivernorth Capital Management's BioPlus Acquisition Corp. Unit position peaked at $1.07M in Q4 2022.
2 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q2 2023.

Based on Rivernorth Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.